Therefore, it is possible that BRG1 functions as a tumor driveror a tumor suppressor in the context of different types of medulloblastomas.Both benign and malignant gliomas, tumors of the glial cells, have increasedlevels of BRG1 relative to nontumorigenic adjacent tissue [96]. This evidence concerns the gene SMARCA4 and malignant glioma.